News

ONEpossible 2025 June 1-July 15. Everywhere
ONEpossible 2025, PRF’s mid-year campaign, kicks off today! Learn how, thanks to YOUR support, PRF is driving every major discovery, ensuring those with Progeria get the unique care they need and leading the charge to the cure!

PRF’s 12th International Scientific Workshop
Join us at our scientific workshop taking place at the Boston Marriott Cambridge Hotel, from October 29-31, 2025, to hear about the latest breakthroughs in Progeria research.

The 2024 Donor Impact Snapshot is here!
Take a look at our newly designed 2024 Donor Impact Snapshot and see the incredible progress we’re making thanks to our amazing team, which includes YOU!

PRF Co-Founders Drs. Leslie Gordon and Scott Berns speak as thought leaders at CiMUS, Spain
The Center for Research in Molecular Medicine and Chronic Diseases (CiMUS) at the University of Santiago in Spain invited PRF co-founders to share their story at a special event on Rare Disease Day 2025.

New clinical trial with the drug Progerinin is officially underway
PRF is thrilled to announce that the first Progerinin clinical trial patient visits are complete!

Long-time friend and PRF supporter Chip Foose supports PRF with truck auction!
Wow – a HUGE thank you to renowned automotive designer Chip Foose and our friends at RealTruck for a very generous donation to PRF!

Get PRF’s 2024 Newsletter here!
PRF’s 2024 Newsletter is OUT – check it out for details on the launch of the NEW Progeria clinical trial, get exciting updates on the lives of those you’re supporting, and SO MUCH MORE.

PRF is a member of the 2025 Bank of America Boston Marathon Official Charity Program!
PRF is proud to be a part of the 129th Boston Marathon® presented by Bank of America. Our team of 10 runners will hit the streets on April 21, 2025!

Mourning the loss of PRF Ambassador, Sammy Basso
The Progeria Research Foundation honors the life of Progeria researcher and advocate, Sammy Basso. Sammy sadly passed away at the age of 28 on October 5, 2024.

BIG NEWS: Announcing the launch of a brand-new clinical drug trial!
We’re back at it! PRF is thrilled to announce the start of a new Progeria clinical trial with a new drug called Progerinin.